Detection of alloimmunization to ensure safer transfusion practice

Area of Science:

• Transfusion Medicine
• Immunology
• Blood Banking

Background:

• Serological safety is crucial for blood banks, necessitating regular Red Blood Cell (RBC) antibody screening.
• Preventing alloimmunization involves issuing antigen-negative blood to alloantibody-positive patients.
• Leukodepleted blood and phenotypic matching are considered for reducing alloimmunization.

Purpose of the Study:

• To evaluate the alloimmunization rate in multiply transfused patients.
• To assess the effectiveness of routine antibody screening and antigen-negative blood transfusion.
• To highlight the importance of serological safety in blood transfusion practices.

Main Methods:

• Analyzed repeat samples from 306 multi-transfused patients between February 2008 and June 2009.
• Utilized Column Agglutination Technology (CAT) and Solid Phase Red Cell Adherence Technology (SPRCAT) for antibody screening and identification.
• Transfused patients with leukoreduced red blood cells using integral filter blood bags.

Main Results:

• An alloimmunization rate of 4.24% was detected among the 306 patients studied.
• The study indicates that transfusion therapy can become complicated by alloimmunization.
• Routine screening and identification are vital for safe transfusion outcomes.

Conclusions:

• Red cell antibody screening and identification, coupled with issuing antigen-negative blood, significantly enhance blood safety.
• Implementing antibody screening and identification protocols ensures safer transfusions.
• Database flagging, patient education, and potential full red cell phenotyping are recommended for improved management.